Patients should seek medical advice for severe abdominal pain, signs of hypoglycaemia, or allergic reactions
October 2023: JAMA Research Letter Warns of Possible Ozempic Risks A research letter filed in the Journal of the American Medical Association alleges the risk of adverse gastrointestinal events associated with the use of GLP-1 agonists that are used not only to treat diabetes but also off-label for weight loss
And its not just eating and weight loss
c Injection site reactions include injection siteassociated events of erythema, pruritus, oedema, pain, induration, bruising, reaction, swelling, haemorrhage, hypersensitivity, hematoma, nodule, discoloration, erosion, inflammation, irritation, warmth, atrophy, discomfort, dryness, mass, hypertrophy, rash, scar, abscess and urticaria